Press Releases

Biofourmis Earns FDA’s First-Ever Breakthrough Device Designation for a Novel Digital Therapeutic for Heart Failure

Biofourmis completed a proof of concept study for its heart failure digital therapeutic BiovitalsHF that met its endpoint of number of patients at 50% of optimal therapy. As a result, FDA has granted the DTx the first-ever Breakthrough Designation for a heart failure digital therapy.

Sensyne grows medical research dataset to 60 million patients

Deep longitudinal, disease agnostic structured global dataset, covering over 4,000 indications will industrialize Sensyne’s life sciences activities

Glyscend Therapeutics Announces Preclinical Data at ADA 2021 on the Metabolic Benefits of its Oral Polymer-based Duodenal Exclusion Therapy

Glyscend Inc has presented data during the American Diabetes Association 80th Scientific Sessions virtual meeting, from a study of its proprietary oral polymer duodenal exclusion therapy.

Speranza Therapeutics Announces Value-Based Program for Opioid Detox Facilities Program vows to reduce costly facility Against Medical Advice (AMA) Leave rates

Speranza Therapeutics has announced the launch of a value-based program for treatment facilities to reduce patient Against Medical Advice (AMA) rates utilizing the S.T. Genesis device.

Curebase Names Paul Donnelly as Senior Vice President of Enterprise Strategy

Curebase Names Paul Donnelly as Senior Vice President of Enterprise Strategy

DFE Pharma demonstrates Impact of Powder Properties on the Rheological Behavior of Excipients

Veranex Announces Acquisition of Experien Group

Veranex, the first concept-to-commercialization global service provider dedicated to the medtech industry, today announced the acquisition of Experien Group, a leading provider of a full range of regulatory, quality, and clinical consulting services to medtech companies.

Heraeus completes multi-million Euro cancer therapy API capacity expansion

Heraeus Pharmaceutical Ingredients’ additional production line for Platinum-based highly potent active pharmaceutical ingredients (Pt hAPIs) is now fully operational at the company’s headquarters in Hanau, Germany.

NanoImaging Services Welcomes its First Chief Operating Officer as Company’s Expansion of Talent Continues

NanoImaging Services today announced the hire of its first Chief Operating Officer, Brian Conkle, as the company continues its rapid growth.

Panthera steps up its move into oncology trials with more than 12 trials in the pipeline and a prostate trial underway

Many cancer clinical research trials were put on hold during Covid – now Panthera Biopartners and Rutherford Health are working in partnership to accelerate oncology research in order to provide improved care for patients.

Histobiolab: One-Stop Source for Blood Samples to Support Studying Progress of Disease Processes

Combination of Viral Therapy and T Cell Therapy to Improve The Cure Rate of Cancer

IntegrateRNA Offers High-quality Oligonucleotide Conjuagted to Facilitate Diagnostic and Targeted Drug Delivery

Sensyne Health and Sentara Healthcare Form New Partnership for Ethical Data Sharing and Design of New Clinical Algorithms

ADVANZ PHARMA partners with Ashfield Engage to deliver talent acquisition strategy for European specialty medicine division

Ashfield Engage, part of UDG Healthcare plc, announced that it has partnered with ADVANZ PHARMA to develop and deliver a pan-European talent acquisition programme for ADVANZ PHARMA’s specialty medicine division.

Noxopharm Pre-clinical Study Confirms Survival Advantage of Combination LuPSMA Therapy in Prostate Cancer

Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) has reported pre-clinical data confirming a survival benefit of adding Veyonda® to 177lutetium-PSMA-617 (LuPSMA) treatment in prostate cancer.

Clinical Ink CBO Jonathan Andrus Selected as DTRA Co-Leader

Clinical Ink, a global clinical trial technology company, today announced that CBO Jonathan Andrus has been selected to co-lead the Decentralized Trials & Research Alliance’s (DTRA) Initiative 4B: Collaborate on Regulatory Gaps.

Enveda Biosciences Boosts its Translational Capabilities with Two Key Hires

Biotium Launches Optimized Solution for Exosome Detection by Flow Cytometry

Biotium Launches Optimized Solution for Exosome Detection by Flow Cytometry

MicrobioSeq Division Releases Viral Metagenomics Services to Study Viruses